Randomized, double-blind, phase III study of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer.


Cortes J., Cescon D. W. , Rugo H. S. , Nowecki Z., Im S., Yusof M. M. , ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.38, 2020 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 38 Konu: 15
  • Basım Tarihi: 2020
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY